- Home
- LNTH vs AXS Comparison
LNTH vs AXS Comparison
Compare LNTH & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- AXS
- Stock Information
- Founded
- LNTH 1956
- AXS 2001
- Country
- LNTH United States
- AXS Bermuda
- Employees
- LNTH N/A
- AXS N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AXS Property-Casualty Insurers
- Sector
- LNTH Health Care
- AXS Finance
- Exchange
- LNTH Nasdaq
- AXS Nasdaq
- Market Cap
- LNTH 3.6B
- AXS 7.4B
- IPO Year
- LNTH 2015
- AXS N/A
- Fundamental
- Price
- LNTH $51.74
- AXS $95.96
- Analyst Decision
- LNTH Strong Buy
- AXS Buy
- Analyst Count
- LNTH 6
- AXS 8
- Target Price
- LNTH $89.67
- AXS $111.43
- AVG Volume (30 Days)
- LNTH 1.5M
- AXS 505.1K
- Earning Date
- LNTH 11-05-2025
- AXS 10-29-2025
- Dividend Yield
- LNTH N/A
- AXS 1.78%
- EPS Growth
- LNTH N/A
- AXS 43.49
- EPS
- LNTH 3.77
- AXS 10.40
- Revenue
- LNTH $1,520,653,000.00
- AXS $6,237,556,000.00
- Revenue This Year
- LNTH N/A
- AXS $2.94
- Revenue Next Year
- LNTH $3.24
- AXS $10.13
- P/E Ratio
- LNTH $13.74
- AXS $9.52
- Revenue Growth
- LNTH 5.75
- AXS 7.72
- 52 Week Low
- LNTH $47.25
- AXS $77.21
- 52 Week High
- LNTH $118.21
- AXS $107.19
- Technical
- Relative Strength Index (RSI)
- LNTH 36.67
- AXS 43.71
- Support Level
- LNTH $51.94
- AXS $96.27
- Resistance Level
- LNTH $55.24
- AXS $99.92
- Average True Range (ATR)
- LNTH 1.86
- AXS 1.72
- MACD
- LNTH 0.36
- AXS -0.11
- Stochastic Oscillator
- LNTH 2.06
- AXS 4.92
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.